Kathan Parikh

Development of GPC2-directed chimeric antigen receptors using mRNA for pediatric brain tumors

Protein cross-linking by chlorinated polyamines and transglutamylation stabilizes neutrophil extracellular traps

A split, conditionally active mimetic of IL-2 reduces the toxicity of systemic cytokine therapy

Clinical lessons learned from the first leg of the CAR T cell journey

CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?

Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs

Inflammation and tumor progression: signaling pathways and targeted intervention

Programming CAR-T cells to kill cancer

Neutrophil extracellular traps in immunity and disease

CAR-T cell therapy: current limitations and potential strategies

Making CAR T Cells a Solid Option for Solid Tumors

Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML

De novo design of tyrosine and serine kinase-driven protein switches

Chimeric antigen receptor–modified T cells: CD19 and the road beyond

Chimeric Antigen Receptor Therapy

CAR T-Cells Targeting the Integrin αvβ6 and Co-Expressing the Chemokine Receptor CXCR2 Demonstrate Enhanced Homing and Efficacy against Several Solid Malignancies

Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

Treatment of Acute Myeloid Leukemia with T Cells Expressing Chimeric Antigen Receptors Directed to C-type Lectin-like Molecule 1

Histone induced platelet aggregation is inhibited by normal albumin